Your cart is currently empty.
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are changing how we approach weight loss. Originally used to treat type 2 diabetes, these medications are now commonly prescribed—even for non-diabetic patients—through online platforms and telehealth providers.
But with all the hype, it’s important to separate facts from fiction. Here’s what you really need to know about GLP-1 weight loss.
How GLP-1 Medications Help You Lose Weight
GLP-1 (glucagon-like peptide-1) is a hormone that impacts insulin regulation and appetite. The medications mimic this hormone, leading to:
- Slower stomach emptying (so you feel fuller longer)
- Reduced cravings and appetite
- Improved portion control without feeling restricted
- Better control over blood sugar and metabolism
Patients often begin losing weight within the first few weeks, and some report 15–20% total body weight loss with consistent use.
What Medications Are Considered GLP-1s?
The most prescribed GLP-1 medications for weight loss in 2025 include:
- Ozempic (semaglutide)
- Wegovy (semaglutide at higher doses)
- Mounjaro/Zepbound (tirzepatide, a dual GIP/GLP-1 receptor agonist)
- Compounded versions of semaglutide or tirzepatide
All of these are now available online, even without insurance, through platforms like Meya.
GLP-1 Side Effects You Should Be Ready For
While GLP-1 medications are generally well tolerated, they aren’t side-effect free. The most common include:
- Nausea (especially during the first 1–2 weeks)
- Constipation or bloating
- Fatigue or lightheadedness
- Mild acid reflux or burping
These side effects are usually temporary and ease as your body adjusts. Providers often start patients on a low dose and increase slowly to minimize symptoms.
Is GLP-1 Weight Loss Safe for Non-Diabetics?
Yes—GLP-1 medications are now widely used off-label for non-diabetic weight loss, especially for people with a BMI over 30 or over 27 with weight-related conditions. Studies show similar results and safety profiles in both diabetic and non-diabetic populations.
Online services like Meya screen patients through a medical intake before prescribing.
Is It Worth It Without Insurance?
Absolutely. While insurance coverage can be hit or miss, cash-pay telehealth providers now offer GLP-1 treatments for as low as $196/month, including meds, provider support, and shipping.
You’ll avoid:
- Insurance rejections
- Pharmacy delays
- Surprise bills
And get fast, affordable care from licensed professionals.
Conclusion: GLP-1s Are Effective—If You’re Ready for the Commitment
GLP-1 weight loss isn’t a quick fix—but it is a powerful tool for people ready to make real, lasting changes. With medical supervision and a proper treatment plan, it can lead to dramatic results with fewer ups and downs than traditional dieting.
Want real GLP-1 treatment without the $1,300/month price tag? Start with Meya for just $196/month.
